Ocular Science Revenue and Competitors

We believe in ingenuity and innovation to create new solutions to old problems. We are Ocular Science®, a leading-edge biotech company focused on developing innovative eye care products at reasonable prices for those suffering from eye disease and discomfort. We do this because eye care patients and physicians should not have to endure Big Pharma’s expensive and overly complex treatments when there are easier and more cost-effective alternatives. Through our affiliate companies, OSRX and Regenerative Science, we blend practical solutions with paradigm-shifting innovations to effect positive change. We can combine and compound multiple medications into a single drop for postoperative cataract and LASIK and glaucoma care that increases compliance and results while reducing cost. This saves time for both patients and doctors by simplifying treatment plans and reducing office callbacks. Our advances in regenerative care and biologics allow us to produce the only amnion-derived drops on the market for those with dry eye disease – Genesis 2.0, ACE and Renaissance. Patients no longer have to suffer through this debilitating condition with big brand synthetic medications that offer half measures and minimal results. We don’t have to settle for old solutions. We can do better. We can create new innovations and treatments that improve upon existing care. We can help patients and doctors save time and money. We can shape the future of visionary care. It’s time to start seeing things differently.